Close

Analyst Ratings for Summit Therapeutics plc (SMMT) [Sells]

SMMT Rating Summary

SMMT Price Target Summary

* Over Last 12-Mos
  |   Expand Research on SMMT
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $8.00 (+114.5%) * Over Last 12-Mos
Rating Score: 5 / 10   Percentile Rank: 53%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details